Program Official
Brandy Heckman-Stoddard, Ph.D., M.P.H.

Principal Investigator

Charles D.
Blanke
Awardee Organization

Oregon Health & Science University
United States

Fiscal Year
2024
Activity Code
UG1
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date
Notice of Funding Opportunity
NIH RePORTER
For more information, see NIH RePORTER Project 5UG1CA189974-11

SWOG NCORP Research Base

The SWOG National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base (RB) has established itself as an innovative, collaborative, and integral part of the NCI's publicly funded cooperative group enterprise. The overall mission of the SWOG NCORP RB is to rapidly design, activate and complete biologically-driven, scientifically important, and clinically meaningful studies in cancer prevention, control, and cancer care delivery, in adults, adolescents and young adults with or at risk for cancer, and to improve quality of life and quality of survivorship for those with malignancies. Over the last grant cycle, the SWOG NCORP RB exceeded expectations with regard to scientific productivity, rapid dissemination of results, inclusiveness, faculty and student training, administrative efficiency, novel and complex trial designs, and advancement of and incorporation of the patient voice into all aspects of our work. In particular, the SWOG NCORP RB opens high-impact trials and conducts and completes them efficiently. During the reporting period, we accrued a total of 11,470 patients, of which 9897 (86%) were placed onto SWOG-coordinated studies, and 1573 (14%) were SWOG sites enrolling onto non-SWOG studies. SWOG NCORP institutions provided 45% of the accrual (n=4451) to SWOG-coordinated studies. Our results are widely disseminated and have informed multiple practice symptom management and survivorship guidelines. We published results from a large number of studies conducted during the last two cycles (125 manuscripts; 58 abstracts), with 34% issued in journals with an impact factor > 10. Overall, 96 NCORP site members were represented as authors in 54 NCORP manuscripts and abstracts. Over the next grant cycle, we will continue to expand our administrative and data infrastructure, with initiatives addressing patient reported outcomes, a robust and modern data management and patient reported outcomes core, enhanced engagement with community investigators and non-traditional partners, augmented education and involvement of patient advocates, and new quality initiatives. We will expand our research efforts in healthcare disparities across all committees, and we will collaboratively design, conduct, and accrue to novel and practice changing studies, in order to reduce the burden of cancer

Publications

  • Lee S, Zhang S, Ma C, Ou FS, Wolfe EG, Ogino S, Niedzwiecki D, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Gross CP, Irwin ML, Meyerhardt JA, Fuchs CS. Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance). JNCI cancer spectrum. 2021 Apr 12;5. (3). doi: 10.1093/jncics/pkab034. eCollection 2021 Jun. PMID: 34104867
  • Phipps AI, Shi Q, Zemla TJ, Dotan E, Gill S, Goldberg RM, Hardikar S, Jahagirdar B, Limburg PJ, Newcomb PA, Shields A, Sinicrope FA, Sargent DJ, Alberts SR. Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2018 Jun;27(6):696-703. Epub 2018 Mar 21. PMID: 29563133
  • Steuer CE, Jegede OA, Dahlberg SE, Wakelee HA, Keller SM, Tester WJ, Gandara DR, Graziano SL, Adjei AA, Butts CA, Ramalingam SS, Schiller JH, ECOG-ACRIN 1505 Investigators. Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2021 Jun;16(6):960-967. Epub 2021 Feb 1. PMID: 33539971
  • Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, Sharer CW, Burton GV, Kuzma CS, Moseley A, Lew DL, Fisch MJ, Moinpour CM, Hershman DL, Wade JL 3rd. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Feb 1;36(4):326-332. Epub 2017 Nov 14. PMID: 29136387
  • Greenlee H, Lew DL, Hershman DL, Newman VA, Hansen L, Hartman SJ, Korner J, Shi Z, Sardo Molmenti CL, Sayegh A, Fehrenbacher L, Lo S, Klemp J, Rinn K, Robertson JM, Unger J, Gralow J, Albain K, Krouse R, Fabian C. Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Obesity (Silver Spring, Md.). 2018 Oct;26(10):1539-1549. Epub 2018 Sep 11. PMID: 30272836
  • Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD. Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients. Future oncology (London, England). 2016 May;12(10):1219-31. Epub 2016 Mar 8. PMID: 26952901
  • Roth ME, Parsons SK, Ganz PA, Wagner LI, Hinds PS, Alexander S, Bingen K, Bober SL, Brackett J, Cella D, Henry NL, Indelicato DJ, Johnson RH, Miller TP, Rosenberg SM, Schmitz KH, Thanarajasingam G, Reeve BB, Salsman JM. Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials. Journal of the National Cancer Institute. 2023 Jan 10;115(1):21-28. PMID: 36266760
  • Albain KS, Gray RJ, Makower DF, Faghih A, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Wood WC, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW, Sparano JA. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial. Journal of the National Cancer Institute. 2021 Apr 6;113(4):390-399. PMID: 32986828
  • Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O, International Breast Cancer Study Group, POSITIVE Trial Collaborators, Azim HA Jr, Peccatori F, Ribi K, Abi-Khattar C, Amant F, Barbro Sætersdal A, Bjelic-Radisic V, Blacher L, Borges V, Borrego MR, Borstnar S, Cardoso F, Colleoni M, Demeestere I, Di Leo A, Eon Lee J, Ferreiro T, Gelber R, Gelmon K, Hiltbrunner A, El-Abed S, Ignatiadis M, Jani P, Kammler R, Walshe JM, Kroep J, Loi S, Mailliez A, Mavroudis D, Moore H, Naughton M, Niman SM, Paluch-Shimon S, Rabaglio M, Regan MM, Roschitzki H, Ruddy K, Ruepp B, Ruggeri M, Saunders C, Saura C, Shaw H, Shimizu C, Smith KL, Spanic T, Susnjar S, Symmans F, Viale G, Boyle F, Jerusalem G, Stahel R, Aebi S, Baas P, McGregor K, Peters S, Popat S, Rosell R, Achille G, Adam S, Alleman S, Campus I, Carrer-Wagner A, Celotto D, Comune C, Fournarakou M, Frapolli M, Gasca A, Giacomelli N, Hahn B, Karagol R, Keglowich L, Maddox C, Maibach R, Marbot M, Mathys M, Pardo Contreras M, Nesa M, Nobs L, Pfister R, Roux S, Rugiati E, Sanchez-Hohl M, Schneider M, Schroeder J, Sicher P, Troesch S, Wagner M, Weber M, Wenger M, Wiedemann M, Wyss F, Zenklusen I, Zigomo I, Züger D, Bouzan C, Cole B, Gelber S, Huang H, Mahoney C, Northrop L, Sun Z, Blackwell M, Harrison D, Fischer S, Kassab G, Mundy L, Narayanan D, Palermo V, Polizzi D, Scott K, Starkweather R, Swick-Jemison J, Veira Y, Weinbaum D, Bernhard J, Andrighetto S, Ciocca F, Dell'Orto P, Russo L, Benini E, Arrigoni L, Schina I, Dechene J, Rothé F, Maetens M, Goldhirsch A, Korde L, Piccart M, Schmitz S, El-Abed S, De Swert H, Jooris M, Leemans J, Questiaux G, Beaupère L, Straehle C, Mooney M, Colleoni M, Artioli F, Cretella E, Gallerani E, Sanna G, Chini C, Ferro A, Spazzapan S, Seles E, De Giorgi U, Tausch C, Rossi L, Rabaglio M, Zaman K, Vetter M, Dedes K, Bodmer A, Leo C, Riniker S, Borner M, Membrez V, Amant F, Gombos A, Jerusalem G, Quaghebeur C, Borstnar S, El Saghir NS, Saura C, Iranzo V, Perelló A, Luna Barrera AM, González X, Cardoso F, Guerra J, Sanchez Henarejos P, Virizuela JA, López R, Andrés R, Kataoka A, Takei J, Nakamura S, Shien T, Tugawa K, Bando H, Kawashima M, Tokunaga E, Tada H, Kawano J, Masuda N, Yoshida M, Takahashi M, Tamura K, Egawa C, Shimuzu C, Partridge AH, Dilawari AA, Flaum E, McAndrew PF, Casteel CM, Smith KL, Al Baghdadi T, Cigler T, Sparano JA, DiBella N, Masters GA, Anderson DM, Reeder-Hayes KE, Crawford J, Radford JE, Schwartz GN, Ruiz Dayao Z, Beck AC, William IJ, Warner E, Gelmon KA, Webster M, Haq R, Elser C, Pavic M, Desbiens C, Barbro Sætersdal A, Kroep JR, Mailliez A, Rousset-Jablonski C, Debled M, Borges VF, Sanft TB, Yung RL, Ángel García-Sáenz J, Ruiz-Borrego M, José Bermejo Pérez M, Illarramendi JJ, Del Barco S, Walshe JM, Korpanty G, Keane M, Kennedy J, Saunders C, Bjelic-Radisic V, Greil R, Czech T, Lee JE, Jeong Kim H, Susnjar S, Ballinger TJ, Wapnir IL, Borges VF, Meisel JL, Steen PD, Mavroudis D, Kaufman B, Vici P. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. The New England journal of medicine. 2023 May 4;388(18):1645-1656. PMID: 37133584
  • Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL, COVID-19 and Cancer Consortium, Abidi M, Acoba JD, Agarwal N, Ahmad S, Ajmera A, Altman J, Angevine AH, Azad N, Bar MH, Bardia A, Barnholtz-Sloan J, Barrow B, Bashir B, Belenkaya R, Berg S, Bernicker EH, Bestvina C, Bishnoi R, Boland G, Bonnen M, Bouchard G, Bowles DW, Busser F, Cabal A, Caimi P, Carducci T, Casulo C, Chen JL, Clement JM, Chism D, Cook E, Curran C, Daher A, Dailey M, Dahiya S, Deeken J, Demetri GD, DiLullo S, Duma N, Elias R, Faller B, Fecher LA, Feldman LE, Friese CR, Fu P, Fu J, Futreal A, Gainor J, Garcia J, Gill DM, Gillaspie EA, Giordano A, Glace MG, Grothey A, Gulati S, Gurley M, Halmos B, Herbst R, Hershman D, Hoskins K, Jain RK, Jabbour S, Jha A, Johnson DB, Joshi M, Kelleher K, Kharofa J, Khan H, Knoble J, Koshkin VS, Kulkarni AA, Lammers PE, Leighton JC Jr, Lewis MA, Li X, Li A, Lo KMS, Loaiza-Bonilla A, LoRusso P, Low CA, Lustberg MB, Mahadevan D, Mansoor AH, Marcum M, Markham MJ, Handy Marshall C, Mashru SH, Matar S, McNair C, McWeeney S, Mehnert JM, Menendez A, Menon H, Messmer M, Monahan R, Mushtaq S, Nagaraj G, Nagle S, Naidoo J, Nakayama JM, Narayan V, Nelson HH, Nemecek ER, Nguyen R, Nuzzo PV, Oberstein PE, Olszewski AJ, Owenby S, Pasquinelli MM, Philip J, Prabhakaran S, Puc M, Ramirez A, Rathmann J, Revankar SG, Rho YS, Rhodes TD, Rice RL, Riely GJ, Riess J, Rink C, Robilotti EV, Rosenstein L, Routy B, Rovito MA, Saif MW, Sanyal A, Schapira L, Schwartz C, Serrano O, Shah M, Shah C, Shaw G, Shergill A, Shouse G, Soares HP, Solorzano CC, Srivastava PK, Stauffer K, Stover DG, Stratton J, Stratton C, Subbiah V, Tamimi R, Tannir NM, Topaloglu U, Van Allen E, Van Loon S, Vega-Luna K, Venepalli N, Verma AK, Vikas P, Wall S, Weinstein PL, Weiss M, Wise-Draper T, Wood WA, Xu WV, Yackzan S, Zacks R, Zhang T, Zimmer AJ, West J. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet (London, England). 2020 Jun 20;395(10241):1907-1918. Epub 2020 May 28. PMID: 32473681
  • Rivera DR, Peters S, Panagiotou OA, Shah DP, Kuderer NM, Hsu CY, Rubinstein SM, Lee BJ, Choueiri TK, de Lima Lopes G Jr, Grivas P, Painter CA, Rini BI, Thompson MA, Arcobello J, Bakouny Z, Doroshow DB, Egan PC, Farmakiotis D, Fecher LA, Friese CR, Galsky MD, Goel S, Gupta S, Halfdanarson TR, Halmos B, Hawley JE, Khaki AR, Lemmon CA, Mishra S, Olszewski AJ, Pennell NA, Puc MM, Revankar SG, Schapira L, Schmidt A, Schwartz GK, Shah SA, Wu JT, Xie Z, Yeh AC, Zhu H, Shyr Y, Lyman GH, Warner JL, COVID-19 and Cancer Consortium. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer discovery. 2020 Oct;10(10):1514-1527. Epub 2020 Jul 22. PMID: 32699031
  • Delahanty LM, Wadden TA, Goodwin PJ, Alfano CM, Thomson CA, Irwin ML, Neuhouser ML, Crane TE, Frank E, Spears PA, Gillis BP, Hershman DL, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, Hudis C, Winer EP, A Carey L, Partridge AH, Ligibel JA. The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity (Silver Spring, Md.). 2022 Jan;30(1):28-38. PMID: 34932888
  • Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Borrego MR, Moore HC, Saunders C, Cardoso F, Susnjar S, Bjelic-Radisic V, Smith KL, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O. Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. Breast (Edinburgh, Scotland). 2021 Oct;59:327-338. Epub 2021 Aug 3. PMID: 34390999
  • Roth ME, Unger JM, O'Mara AM, Lewis MA, Budd T, Johnson RH, Pollock BH, Blanke C, Freyer DR. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era. Cancer medicine. 2020 Mar;9(6):2146-2152. Epub 2020 Feb 3. PMID: 32009305
  • Lemieux J, Brundage MD, Parulekar WR, Goss PE, Ingle JN, Pritchard KI, Celano P, Muss H, Gralow J, Strasser-Weippl K, Whelan K, Tu D, Whelan TJ. Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Feb 20;36(6):563-571. Epub 2018 Jan 12. PMID: 29328860
  • Moinpour CM, Unger JM, Ganz PA, Kornblith AB, Gaynor ER, Bowers MA, Gatti GS, Kaminski MS, Erba HP, Wang T, Yoon J, Press OW, Fisher RI. Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208. Journal of cancer survivorship : research and practice. 2017 Feb;11(1):32-40. Epub 2016 Jul 12. PMID: 27405732
  • McLouth LE, Zheng Y, Smith S, Hodi FS, Rao UN, Cohen GI, Amatruda TT, Dakhil SR, Curti BD, Nakhoul I, Chandana SR, Bane CL, Marinier DE, Lee SJ, Sondak VK, Kirkwood JM, Tarhini AA, Wagner LI. Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2023 Jan;32(1):183-196. Epub 2022 Aug 27. PMID: 36029412
  • McLouth LE, Nightingale CL, Dressler EV, Snavely AC, Hudson MF, Unger JM, Kazak AE, Lee SJC, Edward J, Carlos R, Kamen CS, Neuman HB, Weaver KE. Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2021 Apr;30(4):669-675. Epub 2020 Dec 21. PMID: 33355237
  • Stearns V, Jegede OA, Chang VT, Skaar TC, Berenberg JL, Nand R, Shafqat A, Jacobs NL, Luginbuhl W, Gilman P, Benson AB 3rd, Goodman JR, Buchschacher GL Jr, Henry NL, Loprinzi CL, Flynn PJ, Mitchell EP, Fisch MJ, Sparano JA, Wagner LI. A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Jul 1;30(13):2709-2718. PMID: 38640040
  • Nightingale CL, Sterba KR, McLouth LE, Kent EE, Dressler EV, Dest A, Snavely AC, Adonizio CS, Wojtowicz M, Neuman HB, Kazak AE, Carlos RC, Hudson MF, Unger JM, Kamen CS, Weaver KE. Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the field. Cancer. 2021 Feb 15;127(4):639-647. Epub 2020 Nov 2. PMID: 33136296
  • Minasian L, Dimond E, Davis M, Adhikari B, Fagerstrom R, Fabian C, Floyd J, Unger JM, Douglas PS, Mustian KM, Chow EJ, Lipshultz S, Hundley WG, Armenian S, Ky B. The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity. JACC. CardioOncology. 2019 Sep;1(1):105-113. Epub 2019 Sep 24. PMID: 32529192
  • Brown JC, Ma C, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Couture F, Kuebler P, Kumar P, Lewis D, Tan B, Krishnamurthi S, O'Reilly EM, Shields AF, Meyerhardt JA. Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Jan 10;41(2):243-254. Epub 2022 Aug 9. PMID: 35944235
  • Wolfson JA, Grimes AC, Nuno M, Kerber CL, Ramakrishnan S, Beauchemin M, Dickens D, Levine JM, Roth ME, Scialla M, Woods W, Vargas S, Boayue KB, Chang GJ, Stock W, Hershman D, Curran E, Advani A, O'Dwyer K, Luger S, Liu JJ, Freyer DR, Sung L, Parsons SK. Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL. JCO oncology practice. 2024 Apr;20(4):491-502. Epub 2024 Jan 22. PMID: 38252911
  • Ganz PA, Cecchini RS, Julian TB, Margolese RG, Costantino JP, Vallow LA, Albain KS, Whitworth PW, Cianfrocca ME, Brufsky AM, Gross HM, Soori GS, Hopkins JO, Fehrenbacher L, Sturtz K, Wozniak TF, Seay TE, Mamounas EP, Wolmark N. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet (London, England). 2016 Feb 27;387(10021):857-65. Epub 2015 Dec 11. PMID: 26686960
  • Cathcart-Rake EJ, Zemla T, Jatoi A, Weaver KE, Neuman H, Kazak AE, Carlos R, Gansauer L, Unger JM, Pajewski NM, Kamen C. Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups. Cancer. 2019 Apr 15;125(8):1313-1318. Epub 2018 Dec 18. PMID: 30561776
  • Wagner LI, Gray RJ, Sparano JA, Whelan TJ, Garcia SF, Yanez B, Tevaarwerk AJ, Carlos RC, Albain KS, Olson JA Jr, Goetz MP, Pritchard KI, Hayes DF, Geyer CE, Dees EC, McCaskill-Stevens WJ, Minasian LM, Sledge GW Jr, Cella D. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Jun 10;38(17):1875-1886. Epub 2020 Apr 9. PMID: 32271671
  • Vaidya R, Unger JM, Loomba R, Hwang JP, Chugh R, Tincopa MA, Arnold KB, Hershman DL, Ramsey SD. Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation. Cancer research communications. 2023 Sep 28;3(9):1959-1965. PMID: 37707388
  • Lee S, Ma C, Shi Q, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Lewis D, Tan B, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF, Meyerhardt JA. Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Feb 10;41(5):1079-1091. Epub 2022 Nov 11. PMID: 36367997
  • Carlos RC, Sicks JD, Chiles C, Gansauer L, Kamen CS, Kazak AE, Neuman HB, Unger JM, Weaver KE. Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization. Journal of the American College of Radiology : JACR. 2019 Apr;16(4 Pt A):427-434. Epub 2019 Feb 26. PMID: 30819455
  • Kircher S, Duan F, An N, Gareen IF, Sicks JD, Sadigh G, Suga JM, Kehn H, Mehan PT, Bajaj R, Hanson DS, Dalia SM, Acoba JD, Yasar DG, Park ER, Wagner LI, Carlos RC. Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer. JAMA network open. 2024 Jan 2;7(1):e2350844. PMID: 38194233
  • Azim HA Jr, Niman SM, Partridge AH, Demeestere I, Ruggeri M, Colleoni M, Saura C, Shimizu C, Saetersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Klar NJ, Spanic T, Ruddy K, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O, Peccatori FA. Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Aug 10;42(23):2822-2832. Epub 2024 May 29. PMID: 38810178
  • Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL Jr, Gelber RD, Hortobagyi GN, Albain KS, POEMS/S0230 Investigators. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. The New England journal of medicine. 2015 Mar 5;372(10):923-32. PMID: 25738668
  • Snyder RA, He J, Le-Rademacher J, Ou FS, Dodge AB, Zemla TJ, Paskett ED, Chang GJ, Innocenti F, Blanke C, Lenz HJ, Polite BN, Venook AP. Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931). Cancer. 2021 Oct 15;127(20):3801-3808. Epub 2021 Aug 10. PMID: 34374082
  • McNabb S, Harrison TA, Albanes D, Berndt SI, Brenner H, Caan BJ, Campbell PT, Cao Y, Chang-Claude J, Chan A, Chen Z, English DR, Giles GG, Giovannucci EL, Goodman PJ, Hayes RB, Hoffmeister M, Jacobs EJ, Joshi AD, Larsson SC, Le Marchand L, Li L, Lin Y, Männistö S, Milne RL, Nan H, Newton CC, Ogino S, Parfrey PS, Petersen PS, Potter JD, Schoen RE, Slattery ML, Su YR, Tangen CM, Tucker TC, Weinstein SJ, White E, Wolk A, Woods MO, Phipps AI, Peters U. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. International journal of cancer. 2020 Feb 1;146(3):861-873. Epub 2019 Jun 7. PMID: 31037736
  • Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno-de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung CC, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, M Gaziano JM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw KT, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee IM, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníková-Duchoňová B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel AV, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu XO, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Obazee O, Petersen GM, Amundadottir LT. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature communications. 2018 Feb 8;9(1):556. PMID: 29422604
  • Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Kamineni A, Kolonel LN, Kulke MH, Malats N, Olson SH, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Brais L, Bueno-de-Mesquita HB, Basso D, Berndt SI, Boutron-Ruault MC, Bijlsma MF, Brenner H, Burdette L, Campa D, Caporaso NE, Capurso G, Cavestro GM, Cotterchio M, Costello E, Elena J, Boggi U, Gaziano JM, Gazouli M, Giovannucci EL, Goggins M, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Hu N, Hunter DJ, Iskierka-Jazdzewska E, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Neale RE, Oberg AL, Panico S, Patel AV, Peeters PH, Peters U, Pezzilli R, Porta M, Purdue M, Quiros JR, Riboli E, Rothman N, Scarpa A, Scelo G, Shu XO, Silverman DT, Soucek P, Strobel O, Sund M, Małecka-Panas E, Taylor PR, Tavano F, Travis RC, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vashist Y, Vodicka P, Wactawski-Wende J, Wentzensen N, Yu H, Yu K, Zeleniuch-Jacquotte A, Kooperberg C, Risch HA, Jacobs EJ, Li D, Fuchs C, Hoover R, Hartge P, Chanock SJ, Petersen GM, Stolzenberg-Solomon RS, Wolpin BM, Kraft P, Klein AP, Canzian F, Amundadottir LT. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. 2016 Oct 11;7(41):66328-66343. PMID: 27579533
  • Shu X, Chen Z, Long J, Guo X, Yang Y, Qu C, Ahn YO, Cai Q, Casey G, Gruber SB, Huyghe JR, Jee SH, Jenkins MA, Jia WH, Jung KJ, Kamatani Y, Kim DH, Kim J, Kweon SS, Le Marchand L, Matsuda K, Matsuo K, Newcomb PA, Oh JH, Ose J, Oze I, Pai RK, Pan ZZ, Pharoah PDP, Playdon MC, Ren ZF, Schoen RE, Shin A, Shin MH, Shu XO, Sun X, Tangen CM, Tanikawa C, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Wolk A, Woods MO, Wu AH, Peters U, Zheng W. Large-scale Integrated Analysis of Genetics and Metabolomic Data Reveals Potential Links Between Lipids and Colorectal Cancer Risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2022 Jun 1;31(6):1216-1226. PMID: 35266989
  • Kim J, Yuan C, Amundadottir LT, Wolpin BM, Pancreatic Cancer Cohort Consortium (PanScan), Klein AP, Pancreatic Cancer Case–Control Consortium (PanC4), Risch HA, Kraft P. Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2023 Sep 1;32(9):1242-1248. PMID: 37342060
  • Atherton PJ, Watkins-Bruner DW, Gotay C, Moinpour CM, Satele DV, Winter KA, Schaefer PL, Movsas B, Sloan JA. The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591). Journal of pain and symptom management. 2015 Oct;50(4):470-9.e9. Epub 2015 May 30. PMID: 26031708
  • Aglago EK, Kim A, Lin Y, Qu C, Evangelou M, Ren Y, Morrison J, Albanes D, Arndt V, Barry EL, Baurley JW, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, Buchanan DD, Budiarto A, Carreras-Torres R, Casey G, Cenggoro TW, Chan AT, Chang-Claude J, Chen X, Conti DV, Devall M, Diez-Obrero V, Dimou N, Drew D, Figueiredo JC, Gallinger S, Giles GG, Gruber SB, Gsur A, Gunter MJ, Hampel H, Harlid S, Hidaka A, Harrison TA, Hoffmeister M, Huyghe JR, Jenkins MA, Jordahl K, Joshi AD, Kawaguchi ES, Keku TO, Kundaje A, Larsson SC, Marchand LL, Lewinger JP, Li L, Lynch BM, Mahesworo B, Mandic M, Obón-Santacana M, Moreno V, Murphy N, Nan H, Nassir R, Newcomb PA, Ogino S, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Peoples AR, Platz EA, Potter JD, Prentice RL, Rennert G, Ruiz-Narvaez E, Sakoda LC, Scacheri PC, Schmit SL, Schoen RE, Shcherbina A, Slattery ML, Stern MC, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Tian Y, Ulrich CM, van Duijnhoven FJ, Van Guelpen B, Visvanathan K, Vodicka P, Wang J, White E, Wolk A, Woods MO, Wu AH, Zemlianskaia N, Hsu L, Gauderman WJ, Peters U, Tsilidis KK, Campbell PT. A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk. Cancer research. 2023 Aug 1;83(15):2572-2583. PMID: 37249599
  • Ligibel JA, Barry WT, Alfano C, Hershman DL, Irwin M, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, Hahn O, Hudis C, Winer EP, Wadden TA, Goodwin PJ. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. NPJ breast cancer. 2017 Sep 21;3:37. doi: 10.1038/s41523-017-0040-8. eCollection 2017. PMID: 28948213
  • Parsons JK, Pierce JP, Mohler J, Paskett E, Jung SH, Morris MJ, Small E, Hahn O, Humphrey P, Taylor J, Marshall J. Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer. BJU international. 2018 Apr;121(4):534-539. Epub 2017 May 21. PMID: 28437029
  • Ailawadhi S, Jacobus S, Sexton R, Stewart AK, Dispenzieri A, Hussein MA, Zonder JA, Crowley J, Hoering A, Barlogie B, Orlowski RZ, Rajkumar SV. Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials. Blood cancer journal. 2018 Jul 6;8(7):67. PMID: 29980678
  • Parsons JK, Zahrieh D, Mohler JL, Paskett E, Hansel DE, Kibel AS, Liu H, Seisler DK, Natarajan L, White M, Hahn O, Taylor J, Hartman SJ, Stroup SP, Van Veldhuizen P, Hall L, Small EJ, Morris MJ, Pierce JP, Marshall J. Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):140-148. PMID: 31935026
  • Guercio BJ, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Hu FB, Ogino S, Wu K, Willett WC, Giovannucci EL, Meyerhardt JA, Fuchs CS. Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Nov 1;33(31):3598-607. Epub 2015 Aug 17. PMID: 26282659
  • Van Blarigan EL, Fuchs CS, Niedzwiecki D, Ye X, Zhang S, Song M, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Meyerhardt JA. Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2018 Apr;27(4):438-445. Epub 2018 Jan 22. PMID: 29358223
  • Phipps AI, Shi Q, Limburg PJ, Nelson GD, Sargent DJ, Sinicrope FA, Chan E, Gill S, Goldberg RM, Kahlenberg M, Nair S, Shields AF, Newcomb PA, Alberts SR, Alliance for Clinical Trials in Oncology. Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147. International journal of cancer. 2016 Sep 1;139(5):986-95. Epub 2016 May 9. PMID: 27060850
  • Morgans AK, Chen YH, Sweeney CJ, Jarrard DF, Plimack ER, Gartrell BA, Carducci MA, Hussain M, Garcia JA, Cella D, DiPaola RS, Patrick-Miller LJ. Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Apr 10;36(11):1088-1095. Epub 2018 Mar 9. PMID: 29522362

Clinical Trials

Study Name Clinical Trial ID
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors NCT03887702
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery NCT03757949
Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) NCT04496739
A Study of miRNA 371 in Patients With Germ Cell Tumors NCT04435756
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study NCT05568472
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) NCT02728596
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer NCT02728804
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer NCT03418961
Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors NCT04205955
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment NCT05455606
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer NCT03723928
Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses NCT04960787
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer NCT03939481
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors NCT04871542
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy NCT05642611